Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 5Phase 4 4Phase EARLY_PHASE1 3Phase 1 2Phase 2/3 1

Status

Unknown 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Docosahexaenoic Acids × Clear all
NCT07136519 2025-08-22

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

Affiliated Hospital of Guangdong Medical University

Phase 2 Not yet recruiting
30 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03831178 2025-06-26

DHA-WIN

AHS Cancer Control Alberta

Phase 2 Active not recruiting
76 enrolled
Breast

Breast Neoplasms

NCT03936621 2019-05-07

Omega

British Columbia Cancer Agency

Phase 2 Unknown
42 enrolled
Thoracic

Lung Neoplasms

NCT01070355 2011-10-21

EMT

University of Leeds

Phase 2 Completed
88 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown
45 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡